Literature DB >> 28903466

Doxycycline enhances adsorption and inhibits early-stage replication of porcine reproductive and respiratory syndrome virus in vitro.

Yuming Li1, Zhuanchang Wu1, Ke Liu1, Pengfei Qi1, Jinpeng Xu1, Jianchao Wei1, Beibei Li1, Donghua Shao1, Yuanyuan Shi1, Yafeng Qiu1, Zhiyong Ma1.   

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) has an important impact on the pig industry. Doxycycline (Dox) is a second-generation tetracycline widely used for treating bacterial infections. We evaluated the antiviral effect of Dox against PRRSV infection in Marc-145 cells that were susceptible to PRRSV infection. Dox significantly reduced the PRRSV-induced cytopathic effect and effectively restrained PRRSV replication in a dose-dependent manner. The 50% effective concentration of Dox was approximately 0.25 ± 0.05 μg/ml. We also determined the stage at which Dox influenced PRRSV replication, and showed that Dox enhanced PRRSV adsorption and inhibited the early stage of PRRSV replication after viral entry into host cells. These observations demonstrate that Dox is able to restrain PRRSV infection in cultured cells. © FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  adsorption; antiviral activity; antiviral drug; doxycycline; porcine reproductive and respiratory syndrome virus

Mesh:

Substances:

Year:  2017        PMID: 28903466     DOI: 10.1093/femsle/fnx170

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  7 in total

Review 1.  Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Mohammed Alqarni; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

2.  Doxycycline: From Ocular Rosacea to COVID-19 Anosmia. New Insight Into the Coronavirus Outbreak.

Authors:  Chiara Bonzano; Davide Borroni; Andrea Lancia; Elisabetta Bonzano
Journal:  Front Med (Lausanne)       Date:  2020-05-08

Review 3.  Tetracycline and viruses: a possible treatment for COVID-19?

Authors:  Jesús A Mosquera-Sulbaran; Hugo Hernández-Fonseca
Journal:  Arch Virol       Date:  2020-11-02       Impact factor: 2.574

4.  In Vitro Effects of Doxycycline on Replication of Feline Coronavirus.

Authors:  Magdalena Dunowska; Sayani Ghosh
Journal:  Pathogens       Date:  2021-03-07

5.  Combined Effect of Shegandilong Granule and Doxycycline on Immune Responses and Protection Against Avian Infectious Bronchitis Virus in Broilers.

Authors:  Haipeng Feng; Xuezhi Wang; Jingyan Zhang; Kang Zhang; Wenshu Zou; Kai Zhang; Lei Wang; Zhiting Guo; Zhengying Qiu; Guibo Wang; Ruihua Xin; Jianxi Li
Journal:  Front Vet Sci       Date:  2021-12-20

6.  Tetracyclines in COVID-19 patients quarantined at home: Literature evidence supporting real-world data from a multicenter observational study targeting inflammatory and infectious dermatoses.

Authors:  Laura Cristina Gironi; Giovanni Damiani; Elisa Zavattaro; Alessia Pacifico; Pierachille Santus; Paolo Daniele Maria Pigatto; Ottavio Cremona; Paola Savoia
Journal:  Dermatol Ther       Date:  2020-12-29       Impact factor: 3.858

7.  In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2.

Authors:  Mathieu Gendrot; Julien Andreani; Priscilla Jardot; Sébastien Hutter; Océane Delandre; Manon Boxberger; Joel Mosnier; Marion Le Bideau; Isabelle Duflot; Isabelle Fonta; Clara Rolland; Hervé Bogreau; Bernard La Scola; Bruno Pradines
Journal:  Molecules       Date:  2020-10-31       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.